A detailed history of Pacer Advisors, Inc. transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Pacer Advisors, Inc. holds 568,343 shares of ANIP stock, worth $34 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
568,343
Previous 2,433 23259.76%
Holding current value
$34 Million
Previous $154,000 21917.53%
% of portfolio
0.08%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$54.33 - $65.72 $30.7 Million - $37.2 Million
565,910 Added 23259.76%
568,343 $33.9 Million
Q2 2024

Aug 13, 2024

BUY
$58.53 - $68.82 $89,082 - $104,744
1,522 Added 167.07%
2,433 $154,000
Q1 2024

May 10, 2024

BUY
$54.2 - $69.69 $8,943 - $11,498
165 Added 22.12%
911 $62,000
Q4 2023

Jan 16, 2024

BUY
$48.72 - $65.43 $36,345 - $48,810
746 New
746 $41,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.04B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.